When eating, the body converts extra calories, especially from carbs, sugar, fats, and alcohol, into triglycerides.
Two new small interfering RNA (siRNA) therapeutics (both Arrowhead Pharmaceuticals), each targeting different genes involved in the regulation of triglyceride-rich lipoproteins, have been shown to be ...
MADRID, Spain—Olezarsen (Ionis Pharmaceuticals), an antisense oligonucleotide that targets APOC3 messenger RNA (mRNA), successfully lowers triglyceride levels compared with placebo by 6 months among ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback